Medication info
Hyundai Lansoprazole Capsule 15 mg (Lansoprazole Granule)

Hyundai Lansoprazole Capsule 15 mg (Lansoprazole Granule)

Prescription medicationHard capsuleOral
Ingredient · strength
Lansoprazole Granules›176.5mg / 1 capsule
Manufacturer / importer
Hyundai Pharm. Co., Ltd.
Appearance
A hard capsule with a white upper part and yellow lower part filled with white to light brown granules.
Packaging
28 capsules/bottle
Approval status
Active

MFDS item code 201401473 · Approved 2014.03.28 · Insurance code 642003350

Summary

Main use
Treatment and prevention of reflux disease, gastric and duodenal ulcers, Helicobacter pylori infection, and excessive gastric acid secretion
Who takes it
Adults · Children
Adult dose
This drug should be administered before meals. For patients who have difficulty swallowing the medicine, open the capsule, mix this drug with a small amount (60 mL) of orange juice or tomato juice, and administer immediately. To ensure the entire dose is taken, rinse the glass with twice or more the amount of juice and drink immediately. Do not chew or crush this drug after opening the capsule. Short-term treatment of active duodenal ulcers: Administer lansoprazole 15 mg orally once daily for 4 weeks. Short-term treatment of active benign gastric ulcers: Administer lansoprazole 30 mg orally once daily for 8 weeks. Eradication of Helicobacter pylori to prevent recurrence of duodenal ulcers 1) Administer lansoprazole 30 mg with clarithromycin 250 ∼ 500 mg and amoxicillin 1,000 mg twice daily (every 12 hours) for 7 days. Treatment may be continued for up to 14 days if needed. 2) Administer lansoprazole 30 mg in combination with amoxicillin 1,000 mg 3 times daily (every 8 hours) for 14 days. Maintenance treatment after healing of duodenal ulcers: Administer lansoprazole 15 mg orally once daily. The comparative clinical trial period did not exceed 12 months. Treatment of nonsteroidal anti-inflammatory drug-induced gastric ulcers: Administer lansoprazole 30 mg orally once daily for 8 weeks. The comparative clinical trial period did not exceed 8 weeks. Reduction in the risk of nonsteroidal anti-inflammatory drug-induced gastric ulcers: Administer lansoprazole 15 mg orally once daily for 12 weeks. The comparative clinical trial period did not exceed 12 weeks. Short-term treatment of symptoms associated with gastroesophageal reflux disease Administer lansoprazole 15 mg orally once daily for 8 weeks Short-term treatment of erosive reflux esophagitis: Administer lansoprazole 30 mg orally once daily for 8 weeks. Maintenance treatment after treatment of erosive reflux esophagitis: Administer lansoprazole 15 mg orally once daily. Pathological hypersecretory conditions, including Zollinger-Ellison syndrome The dose of lansoprazole for pathological hypersecretory conditions varies among individual patients. Treatment in adults is usually started at 60 mg once daily. The dose should be adjusted according to the patient's needs and may be continued for as long as it is clinically effective. Doses of 90 mg per dose have been administered up to twice daily. If the daily dose exceeds 120 mg, it should be divided. Because clearance of this drug is reduced in older adults, dose adjustment is necessary. Do not exceed a daily dose of 30 mg. In patients with hepatic impairment, administer cautiously, including dose adjustment, because metabolism and excretion of this drug may be delayed.
Child dose
Children and adolescents aged 12 ∼ 17 years, short-term treatment of symptoms associated with non-erosive gastroesophageal reflux disease: 15 mg once daily for 8 weeks Children and adolescents aged 12 ∼ 17 years, short-term treatment of erosive reflux esophagitis: 30 mg once daily for 8 weeks Children aged 1 ∼ 11 years, 30 kg or less: 15 mg once daily for 12 weeks Children aged 1 ∼ 11 years, over 30 kg: 30 mg once daily for 12 weeks

Ingredients

Manufacturer
Hyundai Pharm. Co., Ltd.

Efficacy & effects

Treatment and prevention of reflux disease, gastric and duodenal ulcers, Helicobacter pylori infection, and excessive gastric acid secretion

  • Active duodenal ulcers
  • active benign gastric ulcers
  • recurrence of duodenal ulcers
  • NSAID-induced gastric ulcers
  • symptoms related to gastroesophageal reflux disease
  • erosive esophagitis
  • Zollinger-Ellison syndrome
  • pathological hypersecretion.
View approved original text

This medication is used for the short-term treatment of active duodenal ulcers and active gastric ulcers. It is also used in eradicating Helicobacter pylori to prevent the recurrence of duodenal ulcers and is effective for maintenance therapy after treatment. It helps in treating NSAID-induced gastric ulcers and reducing the risk of occurrence. It is used for the short-term treatment and maintenance therapy of gastroesophageal reflux disease and erosive esophagitis and controls pathological hypersecretion states such as Zollinger-Ellison syndrome. This medication is used to relieve and treat symptoms of various gastrointestinal disorders.

How to take

Adult dose

This drug should be administered before meals. For patients who have difficulty swallowing the medicine, open the capsule, mix this drug with a small amount (60 mL) of orange juice or tomato juice, and administer immediately. To ensure the entire dose is taken, rinse the glass with twice or more the amount of juice and drink immediately. Do not chew or crush this drug after opening the capsule. Short-term treatment of active duodenal ulcers: Administer lansoprazole 15 mg orally once daily for 4 weeks. Short-term treatment of active benign gastric ulcers: Administer lansoprazole 30 mg orally once daily for 8 weeks. Eradication of Helicobacter pylori to prevent recurrence of duodenal ulcers 1) Administer lansoprazole 30 mg with clarithromycin 250 ∼ 500 mg and amoxicillin 1,000 mg twice daily (every 12 hours) for 7 days. Treatment may be continued for up to 14 days if needed. 2) Administer lansoprazole 30 mg in combination with amoxicillin 1,000 mg 3 times daily (every 8 hours) for 14 days. Maintenance treatment after healing of duodenal ulcers: Administer lansoprazole 15 mg orally once daily. The comparative clinical trial period did not exceed 12 months. Treatment of nonsteroidal anti-inflammatory drug-induced gastric ulcers: Administer lansoprazole 30 mg orally once daily for 8 weeks. The comparative clinical trial period did not exceed 8 weeks. Reduction in the risk of nonsteroidal anti-inflammatory drug-induced gastric ulcers: Administer lansoprazole 15 mg orally once daily for 12 weeks. The comparative clinical trial period did not exceed 12 weeks. Short-term treatment of symptoms associated with gastroesophageal reflux disease Administer lansoprazole 15 mg orally once daily for 8 weeks Short-term treatment of erosive reflux esophagitis: Administer lansoprazole 30 mg orally once daily for 8 weeks. Maintenance treatment after treatment of erosive reflux esophagitis: Administer lansoprazole 15 mg orally once daily. Pathological hypersecretory conditions, including Zollinger-Ellison syndrome The dose of lansoprazole for pathological hypersecretory conditions varies among individual patients. Treatment in adults is usually started at 60 mg once daily. The dose should be adjusted according to the patient's needs and may be continued for as long as it is clinically effective. Doses of 90 mg per dose have been administered up to twice daily. If the daily dose exceeds 120 mg, it should be divided. Because clearance of this drug is reduced in older adults, dose adjustment is necessary. Do not exceed a daily dose of 30 mg. In patients with hepatic impairment, administer cautiously, including dose adjustment, because metabolism and excretion of this drug may be delayed.

Child dose

Children and adolescents aged 12 ∼ 17 years, short-term treatment of symptoms associated with non-erosive gastroesophageal reflux disease: 15 mg once daily for 8 weeks Children and adolescents aged 12 ∼ 17 years, short-term treatment of erosive reflux esophagitis: 30 mg once daily for 8 weeks Children aged 1 ∼ 11 years, 30 kg or less: 15 mg once daily for 12 weeks Children aged 1 ∼ 11 years, over 30 kg: 30 mg once daily for 12 weeks

Precautions

This medication should not be used in patients with a history of allergy or hypersensitivity to certain components or benzimidazole derivatives. Patients allergic to penicillin or macrolide antibiotics should exercise caution when taking this medication. Patients taking certain heart medications or HIV treatments, pregnant women, and patients with lactose intolerance should refrain from using this medication. Patients who have previously experienced allergic reactions to medications, those with impaired liver function, elderly patients, nursing mothers, and children should use this medication cautiously. This medication may rarely cause serious allergic reactions, blood disorders, liver dysfunction, severe skin reactions, etc. If symptoms arise, discontinue administration immediately and consult a healthcare provider. Side effects such as abdominal pain, diarrhea, headache, etc., may occur, and if symptoms are persistent or severe, consult a physician. If taken for a long time, it is advisable to periodically check for nutritional changes such as vitamin B12 deficiency or hypomagnesemia. This medication suppresses gastric acid secretion and may affect the absorption of some medications; therefore, if taking other medications, be sure to inform healthcare providers. It is preferable to avoid taking this medication during pregnancy or breastfeeding; if it must be taken, consult an expert. Special caution is required for dosage adjustment and use in children or elderly patients. In case of an overdose, visit a medical institution immediately to receive appropriate care, as this medication is not removed by dialysis. This medication should be stored in a tightly closed container to avoid exposure to air or moisture and should be kept at a room temperature between 1 to 30 degrees Celsius. This way, the effectiveness of the medication can be maintained for a long time.

Side effects

Anaphylaxis, anaphylactic shock, angioedema, bronchospasm, acute interstitial nephritis, urticaria, generalized rash, facial edema, dyspnea, shock, pancytopenia, agranulocytosis, hemolytic anemia, granulocytopenia, thrombocytopenia, anemia, jaundice, elevated AST, elevated ALT, toxic liver dysfunction, toxic epidermal necrolysis, Stevens-Johnson syndrome, DRESS syndrome, interstitial pneumonia, fever, cough, abnormal pulmonary sounds, interstitial nephritis, acute renal failure, membranous colitis, abdominal pain, frequent diarrhea, headache, diarrhea, abdominal distension, allergic reaction, back pain, weakness, candidiasis, carcinoma, chills, chest pain, edema, fever, flu-like symptoms, halitosis, infection, fatigue, neck stiffness, pelvic pain, angina pectoris, arrhythmia, bradycardia, tachycardia, cerebrovascular accident, cerebral infarction, hypertension, hypotension, migraine, myocardial infarction, palpitations, vasodilation, syncope, asthma, bronchitis, increased cough, epistaxis, hemoptysis, hiccups, pneumonia, upper respiratory infection, laryngeal tumor, pulmonary fibrosis, pharyngitis, pleural disorder, respiratory disorder, rhinitis, sinusitis, wheezing, acne, hair loss, pruritus, rash, contact dermatitis, dry skin, nail disorders, skin cancer, skin diseases, sweating, abnormal vision, amblyopia, blepharitis, cataract, conjunctivitis, dry eyes, ear disease, eye disease, glaucoma, hyposmia, photophobia, retinal degeneration, taste loss, blurred vision, deafness, ocular pain, otitis media, taste anomaly, tinnitus, visual field constriction, urination disorders, renal colic, penile disorders, testicular disorders, urethral pain, polyuria, frequency of urination, urinary retention, menstrual irregularities, chest tenderness, chest expansion, gynecomastia, diabetes, hematuria, erectile dysfunction, kidney stones, abdominal pain, vomiting, pancreatitis, taste disorder, aplastic anemia, thrombotic thrombocytopenic purpura, eosinophilia, hypomagnesemia, Clostridium difficile-associated diarrhea, fracture, myositis, erythema multiforme, acute generalized exanthematous pustulosis, speech disorder, urinary retention, elevated AST, elevated ALT, elevated ALP, elevated LDH, elevated γ-GTP, weakness, hyponatremia, elevated total cholesterol, decreased total cholesterol, tongue paralysis, lip paralysis, limb paralysis, constipation, dizziness, insomnia, paralysis, depressive state, drowsiness, dizziness, unilateral paralysis, confusion, hallucinations, anxiety, amnesia, apathy, worsening hostility, decreased libido, increased libido, neurosis, sensory disturbance, abnormal thinking, convulsions, dementia, depersonalization, diplopia, hyperkinesis, hypertonia, sensory hypoesthesia, insomnia, sleep disorders, drowsiness, tremor

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent the entry of air or moisture and should preferably be kept at a temperature between 1 to 30 degrees Celsius. By storing it this way, the effectiveness of the medication can be maintained for a long time.

Appearance and packaging

Appearance

A hard capsule with a white upper part and yellow lower part filled with white to light brown granules.

Package unit

28 capsules/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.